FHA
BPMC

Flagship Harbor Advisors’s Blueprint Medicines BPMC Stock Holding History

Flagship Harbor Advisors’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-61
Closed -$5K – 692
2020
Q3 		$5K Hold
61
– – ﹤0.01% 1517
2020
Q2 		$4K Hold
61
– – ﹤0.01% 1625
2020
Q1 		$4K Sell
61
-25
-29% -$1.61K ﹤0.01% 1450
2019
Q4 		$7K Hold
86
– – ﹤0.01% 1421
2019
Q3 		$6K Buy
86
+30
+54% +$2.59K ﹤0.01% 1420
2019
Q2 		$5K Buy
+56
New +$4.62K ﹤0.01% 1478

Other funds holding BPMC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Flagship Harbor Advisors's BPMC Position: Q4 2020 in Review

Flagship Harbor Advisors sold out of Blueprint Medicines (BPMC) in Q4 2020, closing a stake of 61 shares — an estimated $5K sold.

Flagship Harbor Advisors first reported a position in BPMC in Q2 2019 and held it in 6 quarters. The position peaked at $7K in Q4 2019. 279 funds tracked by Wall St. Rank hold BPMC as of Q4 2020.

  • Flagship Harbor Advisors reported no remaining Blueprint Medicines position as of Q4 2020 after selling out during the quarter.
  • Flagship Harbor Advisors sold 61 Blueprint Medicines shares in Q4 2020, an estimated $5K.
  • Flagship Harbor Advisors first reported a position in Blueprint Medicines in Q2 2019 and held it in 6 quarters.
  • Flagship Harbor Advisors's Blueprint Medicines position peaked at $7K in Q4 2019.
  • 279 funds tracked by Wall St. Rank held Blueprint Medicines as of Q4 2020.

Based on Flagship Harbor Advisors's 13F filing for Q4 2020, filed 8 Feb 2021.